Kelsey E. McLimans

Cholecystokinin and Alzheimer's disease: a biomarker of metabolic function, neural integrity, and cognitive performance

Alexandra K. Plagman, Siobhan M. Hoscheidt, Kelsey E. McLimans et al. · Neurobiology of Aging · 2019 · 72 citations

Neurodegenerative Diseases, Alzheimer's Disease, Cognitive Performance +13

Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer’s Disease Outcomes

Kelsey E. McLimans, Auriel A. Willette · Journal of Alzheimer s Disease · 2016 · 29 citations · Full text

Is Cerebrospinal Fluid Superoxide Dismutase 1 a Biomarker of Tau But Not Amyloid-Induced Neurodegeneration in Alzheimer's Disease?

Kelsey E. McLimans, Bridget Clark, Alexandra K. Plagman et al. · Antioxidants and Redox Signaling · 2019 · 20 citations · Full text

Peripheral versus Central Index of Metabolic Dysfunction and Associations with Clinical and Pathological Outcomes in Alzheimer’s Disease

Kelsey E. McLimans · Journal of Alzheimer s Disease · 2017 · 16 citations · Full text